A-Fib Catheter Ablation Cuts Risk for Ischemic Stroke After 30 Days, Mortality, Heart Failure Hospitalization

Follow Drugslib on

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on July 7, 2025.

via HealthDay

MONDAY, July 7, 2025 -- For patients with atrial fibrillation, catheter ablation reduces the risks for ischemic stroke at more than 30 days, mortality, and heart failure hospitalization, while surgical ablation only reduces stroke risk, according to a review published online July 1 in the Annals of Internal Medicine.

Bryce Montane, M.D., from Washington University in St. Louis, and colleagues examined the effect of ablation on several outcomes, including ischemic stroke, mortality, and heart failure hospitalization in a review of randomized controlled trials of catheter or surgical ablation versus no ablation that had at least one month of follow-up.

The researchers found that catheter ablation reduced risks for ischemic stroke after 30 days, mortality, and heart failure hospitalization compared with medical therapy (relative risks [95 percent confidence intervals], 0.63 [0.43 to 0.92], 0.73 [0.60 to 0.88], and 0.68 [0.55 to 0.85], respectively). However, catheter ablation also increased the relative risk for ischemic stroke at or before 30 days (relative risk, 6.81; 95 percent confidence interval, 1.56 to 29.8), such that the relative risks (95 percent confidence intervals) for ischemic stroke and stroke from any cause were 0.77 (0.55 to 1.09) and 0.77 (0.57 to 1.05). Surgical ablation reduced the relative risks (95 percent confidence intervals) for ischemic stroke and stroke from any cause (0.54 [0.34 to 0.86] and 0.54 [0.35 to 0.82]); for other outcomes, benefits were uncertain.

"Catheter ablation reduced the risks for ischemic stroke after 30 days, mortality, and heart failure hospitalization," the authors write. "Surgical ablation reduced risks for ischemic stroke and strokes from any cause but had uncertain benefit for other outcomes."

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-07-08 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords